mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.08 |
mRNA |
BRD-K55473186 |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.09 |
mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.09 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.09 |
mRNA |
AZD4547 |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.09 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.09 |
mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.09 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.09 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.09 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.09 |